Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1425485-72-8
1416711-60-8
1017457-67-8 | 1-cyclopropyl-5-oxopyrrolidine-3-carbonitrile | AA00VSJ7 | MFCD10004075
63012-04-4 | (3-Bromophenyl)(phenyl)methanol | AA00VU45 | MFCD00449886
876-89-1 | 6-chlorocinnolin-4-ol | AA00VVH6 | MFCD21086122
21221-92-1 | Pyridin-3-yl(4-(trifluoromethyl)phenyl)methanone | AA012YRC | MFCD13152905
869493-53-8 | 3-(4,4-Difluoro-piperidin-1-yl)-propylamine | AA0188WN | MFCD13184097
446305-66-4 | 2-(3-Bromophenyl)-2-((tert-butoxycarbonyl)amino)acetic acid | AA018GOD | MFCD07388845
918793-32-5 | (2-([4-(Trifluoromethoxy)phenyl]amino)-1,3-thiazol-4-yl)acetic acid | AA018MKC | MFCD11986878
627899-48-3 | 2-(chloromethyl)-5-(4-methoxyphenyl)-1,3-oxazole | AA018RR2 | MFCD09835613
14080-24-1 | N-cyclohexylpyrimidin-2-amine | AA018S3L | MFCD11125390
94924-89-7 | 2-(phenylsulfanyl)pyridin-3-amine | AA018S8M | MFCD00661371